Synthesis and characterization of enzymatically active micrometer protein-capsules
This work describes a general method for the encapsulation of enzymes with albumin as wall material and the enzyme catalase as prime example. Care was taken for the preparation of biochemically active sub-micrometer particles in order to prevent oxygen toxicity induced by artificial oxygen carriers of any type. In cell culture experiments, capsules containing catalase did not exhibit any harmful activities in the absence of peroxides. In the presence of hydrogen peroxide application of low and medium dosed capsules below 0.05 vol% (final concentration 0.001 vol%) even increased the cell damaging process. However, a higher dosage of capsules (>0.05 vol%) prevented completely cellular disruption induced by 5 mM hydrogen peroxide and decreased up to 90% of cellular damage at higher peroxide concentrations. These results demonstrated that encapsulated catalase was enzymatically active and the over-all activity of prepared catalase capsules was determined to be >1900 U mL-1 vol%-1.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Artificial cells, nanomedicine, and biotechnology - 49(2021), 1 vom: 03. Dez., Seite 606-613 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schakowski, Kai Melvin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Albumin: oxygen |
|---|
| Anmerkungen: |
Date Completed 28.01.2022 Date Revised 28.01.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1080/21691401.2021.1955698 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33100724X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33100724X | ||
| 003 | DE-627 | ||
| 005 | 20231225212522.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21691401.2021.1955698 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1103.xml |
| 035 | |a (DE-627)NLM33100724X | ||
| 035 | |a (NLM)34559040 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schakowski, Kai Melvin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synthesis and characterization of enzymatically active micrometer protein-capsules |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.01.2022 | ||
| 500 | |a Date Revised 28.01.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a This work describes a general method for the encapsulation of enzymes with albumin as wall material and the enzyme catalase as prime example. Care was taken for the preparation of biochemically active sub-micrometer particles in order to prevent oxygen toxicity induced by artificial oxygen carriers of any type. In cell culture experiments, capsules containing catalase did not exhibit any harmful activities in the absence of peroxides. In the presence of hydrogen peroxide application of low and medium dosed capsules below 0.05 vol% (final concentration 0.001 vol%) even increased the cell damaging process. However, a higher dosage of capsules (>0.05 vol%) prevented completely cellular disruption induced by 5 mM hydrogen peroxide and decreased up to 90% of cellular damage at higher peroxide concentrations. These results demonstrated that encapsulated catalase was enzymatically active and the over-all activity of prepared catalase capsules was determined to be >1900 U mL-1 vol%-1 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Catalase | |
| 650 | 4 | |a albumin: oxygen | |
| 650 | 4 | |a enzymes | |
| 650 | 4 | |a microcapsules | |
| 650 | 4 | |a microencapsulation | |
| 650 | 4 | |a peroxide | |
| 650 | 7 | |a Capsules |2 NLM | |
| 650 | 7 | |a Hydrogen Peroxide |2 NLM | |
| 650 | 7 | |a BBX060AN9V |2 NLM | |
| 700 | 1 | |a Elm, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Linders, Jürgen |e verfasserin |4 aut | |
| 700 | 1 | |a Kirsch, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Artificial cells, nanomedicine, and biotechnology |d 2013 |g 49(2021), 1 vom: 03. Dez., Seite 606-613 |w (DE-627)NLM219129118 |x 2169-141X |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2021 |g number:1 |g day:03 |g month:12 |g pages:606-613 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21691401.2021.1955698 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2021 |e 1 |b 03 |c 12 |h 606-613 | ||